Pope Asset Management’s Jiangbo Pharmaceuticals, Inc. Common Stock JGBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $0 | Buy |
+744,696
| New | – | ﹤0.01% | 26 |
|
|
2017
Q4 | $0 | Hold |
744,696
| – | – | ﹤0.01% | 28 |
|
|
2017
Q3 | $0 | Hold |
744,696
| – | – | ﹤0.01% | 28 |
|
|
2017
Q2 | $0 | Hold |
744,696
| – | – | ﹤0.01% | 28 |
|
|
2017
Q1 | $0 | Hold |
744,696
| – | – | ﹤0.01% | 28 |
|
|
2016
Q4 | $0 | Hold |
744,696
| – | – | ﹤0.01% | 27 |
|
|
2016
Q3 | $0 | Buy |
+744,696
| New | – | ﹤0.01% | 27 |
|
|
2016
Q1 | $0 | Hold |
744,696
| – | – | ﹤0.01% | 29 |
|
|
2015
Q4 | $0 | Hold |
744,696
| – | – | ﹤0.01% | 29 |
|
|
2015
Q3 | $19K | Hold |
744,696
| – | – | 0.01% | 28 |
|
|
2015
Q2 | $0 | Hold |
744,696
| – | – | ﹤0.01% | 25 |
|
|
2015
Q1 | $19K | Hold |
744,696
| – | – | 0.02% | 22 |
|
|
2014
Q4 | $19K | Hold |
744,696
| – | – | 0.02% | 22 |
|
|
2014
Q3 | $19K | Hold |
744,696
| – | – | 0.01% | 23 |
|
|
2014
Q2 | $19K | Hold |
744,696
| – | – | 0.01% | 24 |
|
|
2014
Q1 | $19K | Hold |
744,696
| – | – | 0.01% | 24 |
|
|
2013
Q4 | $18K | Hold |
744,696
| – | – | 0.02% | 14 |
|
|
2013
Q3 | $19K | Hold |
744,696
| – | – | 0.03% | 14 |
|
|
2013
Q2 | $52K | Buy |
+744,696
| New | +$52K | 0.09% | 14 |
|
Pope Asset Management's JGBO Position: Q3 2018 in Review
Pope Asset Management opened a new position in Jiangbo Pharmaceuticals, Inc. Common Stock (JGBO) in Q3 2018: 744,696 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #26 among its holdings. This is a return to the name: Pope Asset Management previously reported a position in JGBO as recently as Q4 2017.
Pope Asset Management first reported a position in JGBO in Q2 2013 and has held it in 19 quarters since. The position peaked at $52K in Q2 2013. 1 fund tracked by Wall St. Rank holds JGBO as of Q3 2018.
- Pope Asset Management held 744,696 shares of Jiangbo Pharmaceuticals, Inc. Common Stock worth $0 as of Q3 2018.
- Jiangbo Pharmaceuticals, Inc. Common Stock was a new Pope Asset Management position in Q3 2018.
- Jiangbo Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Pope Asset Management's portfolio in Q3 2018, its #26 holding.
- Pope Asset Management first reported a position in Jiangbo Pharmaceuticals, Inc. Common Stock in Q2 2013 and has held it in 19 quarters since.
- Pope Asset Management's Jiangbo Pharmaceuticals, Inc. Common Stock position peaked at $52K in Q2 2013.
- 1 fund tracked by Wall St. Rank held Jiangbo Pharmaceuticals, Inc. Common Stock as of Q3 2018.
Based on Pope Asset Management's 13F filing for Q3 2018, filed 30 Nov 2018.